Oral Vancomycin Followed by Fecal Transplantation Versus Tapering Oral Vancomycin Treatment for RecurrentClostridium difficileInfection: An Open-Label, Randomized Controlled Trial

Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection

(2016) Colleen R. Kelly et al.   ANNALS OF INTERNAL MEDICINE

Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With RecurrentClostridium difficileInfection

(2016) Christine H. Lee et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A High Rate of Alternative Diagnoses in Patients Referred for Presumed Clostridium difficile Infection

(2016) Melissa Jackson et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

A Canadian Working Group Report on Fecal Microbial Therapy: Microbial Ecosystems Therapeutics

(2016) Emma Allen-Vercoe et al.   CANADIAN JOURNAL OF GASTROENTEROLOGY

Canadian Association of Gastroenterology Position Statement: Fecal Microbiota Transplant Therapy

(2016) Paul Moayyedi et al.   Canadian Journal of Gastroenterology and Hepatology

Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrentClostridium difficileinfection

(2015) G. Cammarota et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Fecal Microbiota Transplantation forClostridium difficileInfection

(2015) Dimitri Drekonja et al.   ANNALS OF INTERNAL MEDICINE

Fecal Microbiota Transplant for Relapsing Clostridium difficile Infection Using a Frozen Inoculum From Unrelated Donors: A Randomized, Open-Label, Controlled Pilot Study

(2014) Ilan Youngster et al.   CLINICAL INFECTIOUS DISEASES

Review of the Emerging Treatment of Clostridium difficile Infection with Fecal Microbiota Transplantation and Insights into Future Challenges

(2014) Zain Kassam et al.   CLINICS IN LABORATORY MEDICINE

Fecal Microbiota Transplantation for the Treatment of Clostridium difficile Infection

(2014) Giovanni Cammarota et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Fecal Microbiota Transplantation for Clostridium difficile Infection: Systematic Review and Meta-Analysis

(2013) Zain Kassam et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients

(2013) E. Tacconelli et al.   CLINICAL MICROBIOLOGY AND INFECTION

Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile

(2013) Els van Nood et al.   NEW ENGLAND JOURNAL OF MEDICINE

Defining the Vulnerable Period for Re-Establishment of Clostridium difficile Colonization after Treatment of C. difficile Infection with Oral Vancomycin or Metronidazole

(2013) Turki Abujamel et al.   PLoS One

Systematic review: faecal transplantation for the treatment of Clostridium difficile-associated disease

(2012) B. Guo et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms

(2012) J Gregory Caporaso et al.   ISME Journal

Treating Clostridium difficile Infection With Fecal Microbiota Transplantation

(2011) Johan S. Bakken et al.   Clinical Gastroenterology and Hepatology

Systematic Review of Intestinal Microbiota Transplantation (Fecal Bacteriotherapy) for Recurrent Clostridium difficile Infection

(2011) Ethan Gough et al.   CLINICAL INFECTIOUS DISEASES

Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)

(2010) Stuart H. Cohen et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

QIIME allows analysis of high-throughput community sequencing data

(2010) J Gregory Caporaso et al.   NATURE METHODS

Health Care–AssociatedClostridium difficileInfection in Adults Admitted to Acute Care Hospitals in Canada: A Canadian Nosocomial Infection Surveillance Program Study

(2009) Denise Gravel et al.   CLINICAL INFECTIOUS DISEASES